Bacillus coagulans GBI-30 6086

Bacillus coagulans GBI-30 6086 is a spore-forming probiotic strain that produces lactic acid and antimicrobial compounds to support digestive health. This soil-based probiotic survives stomach acid and colonizes the intestinal tract, promoting beneficial bacteria growth and reducing inflammatory cytokines.

Origin & History

Bacillus coagulans GBI-30 6086 is a soil-based probiotic strain derived from natural soil environments. It is produced through fermentation and is known for its ability to survive in harsh conditions.

Historical & Cultural Context

Bacillus coagulans has been used in traditional fermented foods for its digestive benefits and is a common ingredient in probiotic supplements.

Health Benefits

- Supports digestive health by promoting beneficial gut bacteria, enhancing nutrient absorption. - Enhances immune function through increased antibody production, reducing infection risk. - Reduces inflammation by modulating cytokine levels, promoting comfort. - Improves skin health by reducing systemic inflammation, leading to clearer skin. - Aids in weight management by influencing hormones that regulate appetite. - Boosts mood by producing neurotransmitters like serotonin, enhancing mental well-being. - Supports respiratory health by reducing inflammation, promoting easier breathing.

How It Works

Bacillus coagulans GBI-30 6086 produces lactic acid through lactate dehydrogenase, lowering intestinal pH to inhibit pathogenic bacteria growth. The strain synthesizes antimicrobial bacteriocins and modulates immune responses by reducing pro-inflammatory cytokines IL-6 and TNF-alpha while increasing immunoglobulin A production. Its spore-forming capability allows survival through gastric acid, enabling colonization in the small and large intestines.

Scientific Research

Clinical trials have demonstrated its efficacy in supporting digestive health and reducing IBS symptoms. Studies highlight its stability and resilience.

Clinical Summary

Multiple randomized controlled trials with 50-300 participants demonstrate efficacy for digestive health and immune support. Studies show 2 billion CFU daily reduces IBS symptoms by 20-40% and decreases upper respiratory infections by 27%. A 90-day trial found significant improvements in protein absorption and reduced inflammatory markers. However, most studies are relatively small and short-term, requiring larger long-term trials for definitive conclusions.

Nutritional Profile

- Produces lactic acid, aiding in gut health. - Contains spores that ensure survival through the digestive tract. - Supports the production of beneficial short-chain fatty acids.

Preparation & Dosage

Typically taken in doses of 1-5 billion CFUs per day. Available in capsule or powder form. Consult a healthcare provider before use.

Synergy & Pairings

Fiber, Ginger, Peppermint

Safety & Interactions

Bacillus coagulans GBI-30 6086 is generally well-tolerated with minimal side effects, primarily mild digestive discomfort during initial use. No significant drug interactions are documented, though it may theoretically affect antibiotic absorption if taken simultaneously. Individuals with severely compromised immune systems should consult healthcare providers before use. Safety during pregnancy and lactation has not been established through clinical trials.